KUAISHOU-W
01024
BOSS ZHIPIN-W
02076
XIAOMI-W
01810
NTES-S
09999
ALI HEALTH
00241
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | ---- | 93.04%-1.09B | ---- | -287.90%-15.66B | ---- | -80.44%-4.04B | 98.82%-11.71M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | ---- | -164.03%-616.85M | ---- | 11.64%-233.63M | ---- | 31.53%-264.4M | 32.33%-202.77M |
Investment loss (gain) | ---- | ---- | ---- | ---- | 38.61%-4.98M | ---- | -11.32%-8.11M | ---- | -11.95%-7.29M | -255.11%-625K |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | -64.55%13.04M | ---- | -42.61%36.77M | ---- | -6.64%64.07M | 216.38%12.13M |
Impairment and provisions: | ---- | ---- | ---- | ---- | 103.68%324.89M | ---- | -27.83%159.51M | ---- | -23.02%221.04M | -38.43%165.32M |
-Other impairments and provisions | ---- | ---- | ---- | ---- | 103.68%324.89M | ---- | -27.83%159.51M | ---- | -23.02%221.04M | -38.43%165.32M |
Revaluation surplus: | ---- | ---- | ---- | ---- | -98.56%180.84M | ---- | 161.47%12.53B | ---- | 510.75%4.79B | 310.28%1.51B |
-Other fair value changes | ---- | ---- | ---- | ---- | -98.56%180.84M | ---- | 161.47%12.53B | ---- | 510.75%4.79B | 310.28%1.51B |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | 1,063.44%94.4M | ---- | -129.73%-9.8M | ---- | 814.86%32.96M | 63.91%-1.55M |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | 908.42%116.43M | ---- | -143.70%-14.4M | ---- | 814.86%32.96M | 63.91%-1.55M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | -578.52%-22.03M | ---- | --4.6M | ---- | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | ---- | 28.51%10.02B | ---- | 50.00%7.79B | ---- | 32.11%5.2B | 20.35%3.48B |
-Depreciation | ---- | ---- | ---- | ---- | 55.66%3.06B | ---- | 35.08%1.97B | ---- | 17.23%1.46B | 17.32%1.05B |
-Amortization of intangible assets | ---- | ---- | ---- | ---- | 29.49%485.7M | ---- | 154.76%375.1M | ---- | 3,024.64%147.23M | 1,320.78%44.37M |
Financial expense | ---- | ---- | ---- | ---- | 24.27%893.32M | ---- | 58.07%718.85M | ---- | 5.74%454.77M | -5.64%314.88M |
Exchange Loss (gain) | ---- | ---- | ---- | ---- | 177.42%60.8M | ---- | -47.79%21.92M | ---- | 93.98%41.98M | -1.00%16.39M |
Special items | ---- | ---- | ---- | ---- | 0.76%1.52B | ---- | 74.17%1.51B | ---- | -19.50%865.59M | -0.51%749.88M |
Operating profit before the change of operating capital | ---- | ---- | ---- | ---- | 66.08%11.39B | ---- | -6.82%6.86B | ---- | 85.58%7.36B | 80.81%6.02B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | 103.42%9.93M | ---- | -174.02%-290.21M | ---- | -153.04%-105.91M | -248.15%-24.13M |
Accounts receivable (increase)decrease | ---- | ---- | ---- | ---- | 84.12%-1.1B | ---- | -355.97%-6.94B | ---- | 11.37%-1.52B | 46.50%-857.71M |
Accounts payable increase (decrease) | ---- | ---- | ---- | ---- | 52.74%1.47B | ---- | -5.68%961.07M | ---- | -83.78%1.02B | -58.25%2.56B |
Advance payment increase (decrease) | ---- | ---- | ---- | ---- | -69.65%2.2B | ---- | 107.72%7.24B | ---- | 5,409.11%3.48B | 1,050.59%141.72M |
prepayments (increase)decrease | ---- | ---- | ---- | ---- | 82.79%-305.12M | ---- | -805.29%-1.77B | ---- | 96.85%-195.82M | 76.63%-1.38B |
Special items for working capital changes | ---- | ---- | ---- | ---- | -23,394.31%-700.46M | ---- | -93.67%3.01M | ---- | 311.44%47.48M | 160.05%63.67M |
Cash from business operations | ---- | 72.78%7.08B | ---- | 1.68%4.1B | 113.76%12.96B | 1,636.28%4.03B | -39.91%6.06B | -95.48%231.96M | 337.24%10.09B | 226.01%6.53B |
Other taxs | ---- | -6.73%-301.76M | ---- | -303.35%-282.74M | -45.94%-126.26M | -22.30%-70.1M | -87.56%-86.51M | -190.53%-57.32M | -141.99%-46.13M | 1.22%-18.4M |
Interest received - operating | ---- | 25.10%608.63M | ---- | 255.21%486.52M | 107.93%482.22M | 110.37%136.97M | 46.25%231.92M | -18.81%65.11M | -53.63%158.57M | -53.70%128.31M |
Special items of business | 27.14%20.79B | ---- | --16.35B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 27.14%20.79B | 71.73%7.38B | 22.82%16.35B | 5.00%4.3B | 114.49%13.31B | 1,607.74%4.09B | -39.15%6.21B | -95.38%239.75M | 287.83%10.2B | 193.59%6.64B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | -38.12%6.07M | ---- | --9.8M | --11.29M | ---- | ---- | ---- | ---- | ---- |
Restricted cash (increase) decrease | ---- | -163.39%-13.18M | ---- | 374.72%20.79M | -314.79%-116.88M | -115.76%-7.57M | 51.37%54.42M | --48.01M | --35.95M | ---244K |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | 191.55%35M | ---- | -891.96%-38.23M | ---38.23M |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | 32.44%-3.47B | 464.80%2.91B | -43.20%-5.14B | --515.63M | ---3.59B | ---1.02B |
Sale of fixed assets | ---- | 457.98%586.53M | ---- | 168.93%105.12M | 100.12%157.74M | 67.50%39.09M | 89.21%78.82M | 209.58%23.34M | 148.32%41.66M | -23.62%11.18M |
Purchase of fixed assets | ---- | -7.23%-2.34B | ---- | -53.39%-2.18B | -16.40%-4.83B | 10.14%-1.42B | -30.65%-4.15B | -12.21%-1.58B | -82.01%-3.18B | -4.69%-1.76B |
Purchase of intangible assets | ---- | 37.97%-41.63M | ---- | -127.74%-67.12M | -95.59%-172.37M | -15.50%-29.47M | -97.17%-88.13M | -48.86%-25.52M | -0.79%-44.7M | 62.55%-18.33M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---1.32M | ---1.32M | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---7.71B | ---- | ---- | ---- | ---1.47B | ---1.47B |
Recovery of cash from investments | ---- | 65.13%8.93B | ---- | 180.19%5.41B | -60.02%6.02B | -67.55%1.93B | 165.68%15.06B | 707.43%5.95B | 472,224.92%5.67B | --1.19B |
Cash on investment | ---- | 25.88%-7.84B | ---- | -293.27%-10.58B | 82.37%-2.99B | 55.70%-2.69B | -174.19%-16.96B | -447.68%-6.07B | -641.94%-6.18B | -465.14%-4.3B |
Other items in the investment business | 94.43%-840.45M | ---- | ---15.1B | ---- | ---- | ---- | -68.75%-13.5M | ---- | ---8M | ---- |
Net cash from investment operations | 94.43%-840.45M | 90.26%-709.5M | -15.20%-15.1B | -1,095.19%-7.28B | -17.85%-13.11B | 164.04%731.69M | -26.82%-11.12B | 36.35%-1.14B | -236.05%-8.77B | -199.44%-7.41B |
Net cash before financing | 1,492.45%19.95B | 323.71%6.67B | 505.79%1.25B | -161.81%-2.98B | 104.21%206.81M | 634.58%4.83B | -443.57%-4.92B | -126.57%-902.76M | 6,918.90%1.43B | -261.21%-773.59M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -71.47%1.25B | ---- | 186.77%4.39B | 1,563.90%9.48B | 168.42%1.53B | 90.00%570M | --570M | --300M | --300M |
Refund | ---- | 9.16%-3.01B | ---- | -353.17%-3.31B | -878.85%-6.56B | -7,200.00%-730M | 32.06%-670M | ---10M | ---986.11M | ---262.83M |
Issuing shares | ---- | ---- | ---- | ---- | -69.91%6.92B | -69.96%6.92B | 5,093.84%23.01B | --23.05B | --443.04M | --443.04M |
Interest paid - financing | ---- | 5.23%-518.99M | ---- | -40.58%-547.6M | -30.40%-873.3M | -21.09%-389.53M | -58.12%-669.72M | -59.17%-321.7M | -22.54%-423.56M | -17.50%-297.63M |
Absorb investment income | ---- | ---- | ---- | --14.63M | ---- | ---- | -12.00%13.2M | -12.00%13.2M | -90.12%15M | -90.12%15M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | 96.00%-3.26M | -51.52%-2.89M | -1,186.31%-81.49M | -27.41%-1.91M | -138.07%-6.34M | ---1.7M |
Other items of the financing business | -107.10%-11.49B | ---- | -313.63%-5.55B | 23.98%-574.89M | -137.21%-1.34B | -33.78%-756.28M | -2,692.71%-565.33M | 62.39%-565.33M | 99.73%-20.24M | 134.71%3.39B |
Net cash from financing operations | -107.10%-11.49B | -61.07%-6B | -474.53%-5.55B | -199.56%-3.72B | -91.08%1.48B | -81.62%3.74B | 544.61%16.6B | 747.33%20.34B | 62.28%-3.73B | 113.18%1.51B |
Effect of rate | 2,394.38%142.16M | -94.65%35.68M | -99.70%5.7M | -28.72%666.36M | 1,883.59%1.88B | 803.32%934.85M | 83.09%-105.67M | -19.64%103.49M | -517.69%-625.06M | -4,009.73%-229.15M |
Net Cash | 297.08%8.46B | 110.10%677.11M | -354.41%-4.29B | -178.29%-6.71B | -85.55%1.69B | -55.94%8.56B | 607.39%11.68B | 7,516.40%19.44B | 76.68%-2.3B | 106.33%739.82M |
Begining period cash | -19.95%17.21B | -19.95%17.21B | 19.93%21.5B | 19.93%21.5B | 182.39%17.92B | 182.39%17.92B | -31.56%6.35B | -31.56%6.35B | -51.82%9.27B | -51.82%9.27B |
Cash at the end | 50.01%25.81B | 15.94%17.92B | -19.95%17.21B | -43.64%15.46B | 19.93%21.5B | 5.93%27.42B | 182.39%17.92B | 168.04%25.89B | -31.56%6.35B | 29.37%9.78B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.